A Study of SGB-7342 in Subjects With Obesity or Overweight

NCT07324850 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity & Overweight

Interventions

DRUG: SGB-7342
DRUG: SGB-7342-Matching placebo

Sponsor

Suzhou Sanegene Bio Inc.